Phase 2 Ovarian Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are willing to take part voluntarily and sign a consent form
• People who have been diagnosed with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (confirmed by tissue testing) and whose cancer has come back and is no longer responding to platinum-based chemotherapy
• People who are generally well enough to carry out daily activities, with a fitness score of 0 or 1 on a standard scale (confirm with trial site)
• People whose doctors expect them to live for more than 12 weeks
• People who have at least one area of cancer that can be measured on scans
• People whose major organs (such as liver, kidneys, and heart) are functioning normally
• People who are capable of having children and agree to use reliable contraception from the time of signing the consent form until at least 6 months after the last dose

Who may not be able to join:

• People who have previously received certain specified treatments (confirm with trial site for details)
• People who are currently using anti-cancer traditional Chinese patent medicines at the time of signing the consent form
• People whose cancer has spread to the brain or spinal area, or who have widespread bone spread
• People who had troublesome fluid build-up around the lungs, heart, or abdomen before joining the study that needed to be drained, or who had a drainage procedure within the 2 weeks before joining
• People who have had another type of cancer within the 5 years before signing the consent form
• People with certain specified heart or blood vessel conditions (confirm with trial site for details)
• People who needed antibiotic treatment given through a drip for an infection within 2 weeks before joining the study
• People who had serious lung disease before joining the study
• People who experienced significant nerve damage or other side effects from previous cancer treatments that had not fully resolved before joining the study
• People who had surgery within 28 days before joining the study and had not yet fully recovered from it
• People who took part in another clinical trial and received an unapproved experimental drug within 30 days before joining this study
• People who are known to be allergic to any ingredient in the study drug B013 or to paclitaxel (a type of chemotherapy)
• People with a known history of substance misuse, alcohol dependence, or drug misuse, or a known history of neurological or psychiatric conditions
• People who are pregnant or breastfeeding
• People considered unsuitable for the trial for other reasons, as determined by the research team or trial sponsor

Important: Always verify eligibility with the trial site directly before applying.